计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| T414219-1mg |
1mg |
现货 ![]() |
| |
| T414219-5mg |
5mg |
现货 ![]() |
| |
| T414219-10mg |
10mg |
现货 ![]() |
| |
| T414219-25mg |
25mg |
现货 ![]() |
|
| 英文别名 | 7H-Pyrrolo[2,3-d]pyrimidin-4-amine,7-[5-[(aminosulfonyl)amino]-5-deoxy-β-D-ribofuranosyl]-5-[2-(2-ethoxy-6-fluorophenyl)ethynyl]- |
|---|---|
| 规格或纯度 | ≥98% |
| 英文名称 | TAS4464 |
| 生化机理 | TAS4464 是一种强效、高选择性的 NEDD8 激活酶(NAE)抑制剂,IC50 为 0.955 nM。TAS4464 具有卓越的抗肿瘤活性,靶点抑制时间长。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
Information TAS4464 TAS4464 is a potent and highly selective NEDD8 activating enzyme (NAE) inhibitor with IC50 of 0.955 nM. TAS4464 exhibits superior antitumor activity with prolonged target inhibition. Targets NAE (Cell-free assay) 0.955 nM In vitro TAS4464 selectively inhibits NAE relative to the other E1s UAE and SAE. TAS4464 treatment inhibits cullin neddylation and subsequently induces the accumulation of CRL substrates such as CDT1, p27, and phosphorylated IkBa in human cancer cell lines. Cytotoxicity profiling reveals that TAS4464 is highly potent with widespread antiproliferative activity not only for cancer cell lines, but also patient-derived tumor cells. In vivo TAS4464 shows prolonged target inhibition in human tumor xenograft mouse models; weekly or twice a week TAS4464 administration led to prominent antitumor activity in multiple human tumor xenograft mouse models including both hematologic and solid tumors without marked weight loss. Cell Research(from reference) Cell lines:PBMC, AML, DLBCL, SCLC cells. Patient-derived ovary and endometrial cells. Hepatocytes. Concentrations:1 nM, 10 nM, 100 nM, 1000 nM Incubation Time:24 h, 72 h, 6 days |
| 纯度 | ≥98% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| IIUPAC Name | 4-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(sulfamoylamino)methyl]oxolan-2-yl]-5-[2-(2-ethoxy-6-fluorophenyl)ethynyl]pyrrolo[2,3-d]pyrimidine |
|---|---|
| INCHI | 1S/C21H23FN6O6S/c1-2-33-14-5-3-4-13(22)12(14)7-6-11-9-28(20-16(11)19(23)25-10-26-20)21-18(30)17(29)15(34-21)8-27-35(24,31)32/h3-5,9-10,15,17-18,21,27,29-30H,2,8H2,1H3,(H2,23,25,26)(H2,24,31,32)/t15-,17-,18-,21-/m1/s1 |
| InChi Key | TZTRUHFXPVXWRD-QTQZEZTPSA-N |
| Smiles | CCOC1=C(C(=CC=C1)F)C#CC2=CN(C3=NC=NC(=C23)N)C4C(C(C(O4)CNS(=O)(=O)N)O)O |
| Isomeric SMILES | CCOC1=C(C(=CC=C1)F)C#CC2=CN(C3=NC=NC(=C23)N)[C@H]4[C@@H]([C@@H]([C@H](O4)CNS(=O)(=O)N)O)O |
| PubChem CID | 124121703 |
| 分子量 | 506.51 |
| 溶解性 | Solubility (25°C) In vitro DMSO: 100 mg/mL (197.42 mM); Water: Insoluble; Ethanol: Insoluble; |
|---|---|
| 分子量 | 506.500 g/mol |
| XLogP3 | 0.200 |
| 氢键供体数Hydrogen Bond Donor Count | 5 |
| 氢键受体数Hydrogen Bond Acceptor Count | 12 |
| 可旋转键计数Rotatable Bond Count | 8 |
| 精确质量Exact Mass | 506.138 Da |
| 单同位素质量Monoisotopic Mass | 506.138 Da |
| 拓扑极表面积Topological Polar Surface Area | 196.000 Ų |
| 重原子数Heavy Atom Count | 35 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 911.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 4 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |